Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-07-005412

Chief Executive Officer acquired 9,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DEES H CRAIG · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2007-03-09 Exercise or conversion : show line 1 in the form +9,375 $0.32 $3,000 1,422,859 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2007-03-09 Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) −9,375 $0.32 2013-05-23 9,375 50,000 D
Loading xslF345X02/doc1.xml…